Skip to main content
. Author manuscript; available in PMC: 2009 Mar 31.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2008;17(1):26–29. doi: 10.1016/j.jstrokecerebrovasdis.2007.09.006

Table 1.

Baseline patient demographics and characteristics

Age, y 64 (mean)
Sex N (%)
Male 21 (52.5%)
Female 19 (47.5%)
Race N
White 13
Black 16
Hispanic-white 11
Hispanic-nonwhite 0
Other 0
History of stroke/TIA N (%)
TIA 2
Infarct 9
ICH 0
NIHSS score (mean)
Admission 6
24 h 4
Discharge/day 7 3
Time to presentation
Male 523 min
Female 586 min
Symptom onset to Rx
Mean 12 h 32 min
Median 8 h 25 min
Admission glucose 153 (mean)
Length of stay 4.75 days
Current antithrombotic use N (%)
Aspirin 3 (7.5%)
Clopidogrel 1 (2.5%)
Aggrenox 2 (5.0%)
Warfarin 1 (2.5%)
None 33 (82.5%)
Time to presentation, N (%)
0-3 h 7 (17.5%)
3 h 1 min-6 h 11 (27.5%)
6 h 1 min-12 h 7 (17.5%)
12 h 1 min-24 h 15 (37.5%)
Discharge disposition N (%)
Home 26 (65.0%)
Inpatient rehabilitation 8 (20.0%)
Skilled nursing facility 2 (5.0%)
Nursing home 1 (2.5%)
Other 2 (5.0%)
NIHSS score on presentation N (%)
0 6 (15%)
1-5 18 (45%)
6-10 9 (22%)
11-15 4 (10%)
16-20 1 (3%)
>20 2 (5%)

ICH, intracranial hemorrhage; NIHSS, National Institutes of Health stroke scale; Rx, prescription; TIA, transient ischemic attack.